Intra-Cellular Therapies

/Intra-Cellular Therapies

J. P. Morgan Securities, Leerink Partners Description:  Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson’s and Alzheimer’s disease.

Symbol

Last Closing Price
$19.23

Shares
7,000,000

Anticipated Date
TBD

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange